Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia (PerProMe)

June 15, 2015 updated by: University Hospital Inselspital, Berne

Prophylactic Mesh Implantation in Patients With Peritonitis for the Prevention of Incisional Hernia: A Randomized Controlled Trial

In patients undergoing laparotomy, the incidence of abdominal wall related complications such as incisional hernia is very high. In particular in patients with peritonitis undergoing laparotomy the incidence of incisional hernia is up to 54.3%. Furthermore, these patients are at great risk for development of postoperative fascial dehiscence.

The gold standard of abdominal wall closure is a running slowly absorbable suture irrespective of the presence of peritonitis. Implantation of an intraperitoneal mesh potentially reduces the incidence of incisional hernia.

In a series of high risk patients in which we implanted non-absorbable intraperitoneal mesh prophylactically we reduced the incidence of incisional hernia down to 3.2%.

Study Overview

Detailed Description

Background

Incisional hernia is a common complication in visceral surgery and varies between 11 and 26% in the general surgical population [1,2]. An incisional hernia is defined as any abdominal wall gap with or without a bulge in the area of postoperative scar perceptible or palpable by clinical examination or imaging [3]. Overall incidence of incisional hernia at our institution with a follow-up of five years was 14%, whereas in patients undergoing liver transplantation we found an incidence of incisional hernia of 25% in a prospective study [2]. However, patients with peritonitis are at very high risk for the development of incisional hernia. Moussavian et al demonstrated an incidence of incisional hernia of 54.3% after a median follow-up of 6 years in patients undergoing emergency surgery for secondary peritonitis [4]. In patients undergoing surgical therapy for secondary peritonitis, redo surgery because of complications associated with the abdominal wall, such as fascial dehiscence and surgical site infection are frequent. Impaired wound healing in response to the systemic inflammatory response and the high incidence of surgical site infection might render the abdominal wall even more susceptible for incisional hernia, compared with the general surgical population [5,6]. Furthermore, patients with peritonitis undergoing emergency laparotomy develop fascial dehiscence in up to 24.1% [7]. Fascial dehiscence requires reoperation and is associated with a mortality rate up to 44% [8].

Objective

To compare prophylactic mesh implantation to conventional abdominal wall closure in patients undergoing emergency laparotomy for peritonitis.

Methods

Implantation of a non-resorbable intraperitoneal mesh in patients with peritonitis undergoing emergency laparotomy.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berne, Switzerland, 3010
        • Dep. of Visceral and transplant surgery, Berne University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with clinical signs of peritonitis
  • Emergency laparotomy or laparoscopy with conversion to laparotomy
  • Patients > 18 years
  • Written informed consent

Exclusion Criteria

  • Previous implanted mesh
  • Incisional hernia present
  • Small bowel obstruction without bowel resection
  • Surgery for cholecystitis
  • Inflammatory bowel disease (Crohn's disease, Ulcerative colitis)
  • Polytrauma patients
  • Pregnant women
  • Women younger than 45 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1
Conventional abdominal wall closure with mesh implantation
To compare prophylactic mesh implantation to conventional abdominal wall closure in patients undergoing emergency laparotomy for peritonitis.
NO_INTERVENTION: 2
Conventional abdominal wall closure without mesh implantation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patients with incisional hernia
Time Frame: 54 months
54 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of patients with facial dehiscence
Time Frame: 54 months
54 months
Mortality
Time Frame: 54 months
54 months
Number of patients with surgical site infection
Time Frame: 54 months
54 months
Number of patients with intestinal fistula
Time Frame: 54 months
54 months
Number of patients with small bowel obstruction
Time Frame: 54 months
54 months
Number of patients with postoperative pain
Time Frame: 54 months
54 months
Number of patients with low grade mesh infection or chronic subclinical inflammation
Time Frame: 54 months
54 months
Number of patients with mesh explantation
Time Frame: 54 months
54 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guido Beldi, Prof. Dr. med., Dep. of visceral and transplant surgery; Univesrity Hiospital, Berne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (ACTUAL)

April 1, 2015

Study Completion (ACTUAL)

April 1, 2015

Study Registration Dates

First Submitted

February 15, 2013

First Submitted That Met QC Criteria

February 27, 2013

First Posted (ESTIMATE)

March 1, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

June 16, 2015

Last Update Submitted That Met QC Criteria

June 15, 2015

Last Verified

June 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on A non-absorbable composite mesh (Ethicon Physiomesh)

Subscribe